The Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) recently released new recommendations for the dosing schedule of Trumenba (Meningococcal Group B) vaccinations.
Leaders and officials with Takeda Pharmaceutical Company Limited recently highlighted their sustained commitment to fighting Hodgkin lymphoma at the 10th International Symposium on Hodgkin Lymphoma (ISHL) in Germany.
The Elton John AIDS Foundation (EJAF), a leading supporter in the worldwide push to end AIDS, recently awarded a total of $4.1 million to various programs that seek to resolve the health and human rights of HIV/AIDS victims.
The University of California at Los Angeles’ (UCLA) Center for Duchenne Muscular Dystrophy (CDMD) was recently selected as the 12th clinic to become a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD).
PatientPoint recently launched a new mobile app that will enable physicians to improve how they practice medicine, in addition to offering patients more information to benefit their overall experience.
In the 'Journal of Autism and Developmental Disorders,' a team of researchers recently wrote that some doctors may be unknowingly over-diagnosing children with autism as having attention deficit hyperactivity disorder (ADHD).
Deaconess and St. Mary’s recently announced that they have received the prestigious Wellness Frontiers Award from the Healthcare Leadership Council (HLC) for their Project AWARE program (Youth Mental Health First Aid).
U.S. leadership in the health care industry recently held a Capitol Hill briefing to highlight the ongoing work against antibiotic-resistant illnesses as well as the serious dangers that come from these diseases.
The National Institutes of Health (NIH) National Eye Institute (NEI) recently funded a study that evaluated the role of the visual cortex, the sensory information processing region of the brain, in plasticity of reflexive eye movements.
Leaders with the National Institutes of Health (NIH) Nutrition Research Task Force (NRTF) have decided to create the first nutrition strategy plan to complement other NIH research efforts against conditions and diseases that are affected by nutrition.
Merck, called MSD outside of Canada and the U.S., recently announced that a representative will present new data about Zepatier, as well as chronic hepatitis C clinical development programs, at The Liver Meeting 2016.